Cadmium reduces 11β-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 1, 2006, Pages

  Yang, Kaiping ^a   Julan, Laura ^b   Rubio, Fran ^b   Sharma, Anju ^b   Guan, Haiyan ^b  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

Environmental toxin; Fetal growth restriction; Glucocorticoid; Placenta

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CADMIUM; COTININE; HEME OXYGENASE 1; MAGNESIUM; MANGANESE; MESSENGER RNA; NICOTINE; ZINC; BETA GALACTOSIDASE; DIVALENT CATION; HMOX1 PROTEIN, HUMAN; HYBRID PROTEIN; LUCIFERASE; NICOTONE; OXAZINE DERIVATIVE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; NUCLEOTIDE SEQUENCE; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; TROPHOBLAST; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CADMIUM; CATIONS, DIVALENT; CELLS, CULTURED; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; LUCIFERASES; OXAZINES; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TROPHOBLASTS;

EID: 33644878490     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00356.2005     Document Type: Article

References (82)

1. Agarwal AK and White PC. Analysis of the promoter of the NAD+ dependent 11 beta-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells. Mol Cell Endocrinol 121: 93-99, 1996.
2. Baranowska I. Lead and cadmium in human placentas and maternal and neonatal blood (in a heavily polluted area) measured by graphite furnace atomic absorption spectrometry. Occup Environ Med 52: 229-232, 1995.
3. Baranski B. Effect of exposure of pregnant rats to cadmium on prenatal and postnatal development of the young. J Hyg Epidemiol Microbiol Immunol 29: 253-262, 1984.
4. Barbieri RL, Gochberg J, and Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 77: 1727-1733, 1986.
5. Berlin M, Blanks R, Catton M, Kazantzis G, Mottet NK, and Samiullah Y. Birth weight of children and cadmium accumulation in placentas of female nickel-cadmium (long-life) battery workers. 257-262.
6. Brodsky D and Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 19: 307-319, 2004.
7. Burton GJ, Palmer ME, and Dalton KJ. Morphometric differences between the placental vasculature of non-smokers, smokers and exsmokers. Br J Obstet Gynaecol 96: 907-915, 1989.
8. Burton PJ and Waddell BJ. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod 60: 234-240, 1999.
9. Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD, and Page KR. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta 21: 247-256, 2000.
10. Castro LC, Allen R, Ogunyemi D, Roll K, and Platt LD. Cigarette smoking during pregnancy: acute effects on uterine flow velocity waveforms. Obstet Gynecol 81: 551-555, 1993.
11. Challis JRG, Matthews SG, Gibb W, and Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21: 514-550, 2000.
12. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6: S125-S140, 2004.
13. Condon JC, Jeyasuria P, Faust JM, Wilson JW, and Mendelson CR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci USA 100: 9518-9523, 2003.
14. Cooke RW. Smoking, intra-uterine growth retardation and sudden infant death syndrome. Int J Epidemiol 27: 238-241, 1998.
15. Derfoul A, Lin FJ, Awumey EM, Kolodzeski T, Hall DJ, and Tuan RS. Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem 89: 755-770, 2003.
16. Di Sant'Agnese PA, Jensen KD, Levin A, and Miller RK. Placental toxicity of cadmium in the rat: an ultrastructural study. Placenta 4: 149-163, 1983.
17. Dy J, Sampath-Kumar R, Richardson B, and Yang K. Placental 11beta-hydroxysteroid dehydrogenase type 2 activity is attenuated in pregnancies complicated with intrauterine growth restriction. Xth International Congress on Hormonal Steroids, Quebec City, Canada, 1998.
18. Fagher U, Laudanski T, Schutz A, Sipowicz M, and Akerlund M. The relationship between cadmium and lead burdens and preterm labor. Int J Gynaecol Obstet 40: 109-114, 1993.
19. Falcon M, Vinas P, Osuna E, and Luna A. Environmental exposures to lead and cadmium measured in human placenta. Arch Environ Health 57: 598-602, 2002.
20. Favatier F and Polla BS. Tobacco-smoke-inducible human haem oxygenase-1 gene expression: role of distinct transcription factors and reactive oxygen intermediates. Biochem J 353: 475-482, 2001.
21. Feng T. Substance abuse in pregnancy. Curr Opin Obstet Gynecol 5: 16-23, 1993.
22. Fiala J, Hruba D, and Rezl P. Cadmium and zinc concentrations in human placentas. Cent Eur J Public Health 6: 241-248, 1998.
23. Frery N, Nessmann C, Girard F, Lafond J, Moreau T, Blot P, Lellouch J, and Huel G. Environmental exposure to cadmium and human birthweight. Toxicology 79: 109-118, 1993.
24. Gartrell MJ, Craun JC, Podrebarac DS, and Gunderson EL. Pesticides, selected elements, and other chemicals in adult total diet samples, October 1980-March 1982. J Assoc Off Anal Chem 69: 146-159, 1986.
25. Gartrell MJ, Craun JC, Podrebarac DS, and Gunderson EL. Pesticides, selected elements, and other chemicals in infant and toddler total diet samples, October 1980-March 1982. J Assoc Off Anal Chem 69: 123-145, 1986.
26. 2. Teratog Carcinog Mutagen 3: 89-100, 1983.
27. Guan H, Arany E, van Beek JP, Chamson-Reig A, Thyssen S, Hill DJ, and Yang K. Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats. Am J Physiol Endocrinol Metab 288: E663-E673, 2005.
28. Hardy DB and Yang K. The expression of 11 beta-hydroxysteroid dehydrogenase type 2 is induced during trophoblast differentiation: effects of hypoxia. J Clin Endocrinol Metab 87: 3696-3701, 2002.
29. Henson MC and Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med (Maywood) 229: 383-392, 2004.
30. Jarup L, Berglund M, Elinder CG, Nordberg G, and Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health 24, Suppl 1: 1-51, 1998.
31. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, and Martin MB. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9: 1081-1084.
32. Jolibois LS Jr, Burow ME, Swan KF, George WJ, Anderson MB, and Henson MC. Effects of cadmium cell viability, trophoblastic development, and expression of low density lipoprotein receptor transcripts in cultured human placental cells. Reprod Toxicol 13: 473-480, 1999.
33. Jolibois LS Jr, Shi W, George WJ, Henson MC, and Anderson MB. Cadmium accumulation and effects on progesterone release by cultured human trophoblast cells. Reprod Toxicol 13: 215-221, 1999.
34. Julan L, Guan H, van Beek JP, and Yang K. Peroxisome proliferator-activated receptor (delta) suppresses 11(beta)-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells. Endocrinology 146: 1482-1490, 2005.
35. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Wood PJ, Nuutila M, and Andersson S. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 88: 493-500, 2003.
36. Kanter M, Yoruk M, Koc A, Meral I, and Karaca T. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Biol Trace Elem Res 93: 189-200, 2003.
37. Kantola M, Purkunen R, Kroger P, Tooming A, Juravskaja J, Pasanen M, Saarikoski S, and Vartiainen T. Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg. Environ Res 83: 54-66, 2000.
38. Kawai M, Swan KF, Green AE, Edwards DE, Anderson MB, and Henson MC. Placental endocrine disruption induced by cadmium: effects on P450 cholesterol side-chain cleavage and 3beta-hydroxysteroid dehydrogenase enzymes in cultured human trophoblasts. Biol Reprod 67: 178-183, 2002.
39. Kitanaka S, Tanae A, and Hibi I. Apparent mineralocorticoid excess due to 11 beta-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin Endocrinol (Oxf) 44: 353-359, 1996.
40. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, and Strauss JF, 3rd. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118: 1567-1582, 1986.
41. Korpela H, Loueniva R, Yrjanheikki E, and Kauppila A. Lead and cadmium concentrations in maternal and umbilical cord blood, amniotic fluid, placenta, and amniotic membranes. Am J Obstet Gynecol 155: 1086-1089, 1986.
42. Kramer MS. Socioeconomic determinants of intrauterine growth retardation. Eur J Clin Nutr 52: S29-S33, 1998.
43. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, and Andrews RK. Immunohistochemical localization of the 11 betahydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995.
44. Kuhnert BR, Kuhnert PM, and Zarlingo TJ. Associations between placental cadmium and zinc and age and parity in pregnant women who smoke. Obstet Gynecol 71: 67-70, 1988.
45. Lanz CB, Causevic M, Heiniger C, Frey FJ, Frey BM, and Mohaupt MG. Fluid Shear stress reduces 11ss-hydroxysteroid dehydrogenase type 2. Hypertension 37: 160-169, 2001.
46. Larsen LG, Clausen HV, and Jonsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol 186: 531-537, 2002.
47. Levin AA and Miller RK. Fetal toxicity of cadmium in the rat: decreased utero-placental blood flow. Toxicol Appl Pharmacol 58: 297-306, 1981.
48. Lin CC and Santolaya-Forgas J. Current concepts of fetal growth restriction: part I Causes, classification, and pathophysiology. Obstet Gynecol 92: 1044-1055, 1998.
49. Lin FJ, Fitzpatrick JW, Iannotti CA, Martin DS, Mariani BD, and Tuan RS. Effects of cadmium on trophoblast calcium transport. Placenta 18: 341-356, 1997.
50. Luciano A, Bolognani M, Biondani P, Ghizzi C, Zoppi G, and Signori E. The influence of maternal passive and light active smoking on intra-uterine growth and body composition of the newborn. Eur J Clin Nutr 52: 760-763, 1998.
51. Malstrom SE, Jekic-McMullen D, Sambucetti L, Ang A, Reeves R, Purchio AF, Contag PR, and West DB. In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice. Toxicol Appl Pharmacol 200: 219-228, 2004.
52. Martin MB, Voeller HJ, Gelmann EP, Lu J, Stoica EG, Hebert EJ, Reiter R, Singh B, Danielsen M, Pentecost E, and Stoica A. Role of cadmium in the regulation of AR gene expression and activity. Endocrinology 143: 263-275, 2002.
53. McAleer MF and Tuan RS. Cytotoxicant-induced trophoblast dysfunction and abnormal pregnancy outcomes: role of zinc and metallothionein. Birth Defects Res C Embryo Today 72: 361-370, 2004.
54. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, and Stewart PM. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 86: 4979-4983, 2001.
55. Misra DP, Astone N, and Lynch CD. Maternal smoking and birth weight: interaction with parity and mother's own in utero exposure to smoking. Epidemiology 16: 288-293, 2005.
56. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, and Clifton VL. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 87: 1660-1668, 2002.
57. Nawrocki AR, Goldring CE, Kostadinova RM, Frey FJ, and Frey BM. In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3. J Biol Chem 277: 14647-14656, 2002.
58. Osmond C and Barker DJ. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 108: 545-553, 2000.
59. Pastrakuljic A, Derewlany LO, and Koren G. Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta 20: 499-512, 1999.
60. Pepe GJ, Burch MG, and Albrecht ED. Expression of the 11beta-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast. Placenta 20: 575-582, 1999.
61. Piasek M, Blanusa M, Kostial K, and Laskey JW. Placental cadmium and progesterone concentrations in cigarette smokers. Reprod Toxicol 15: 673-681, 2001.
62. Pinot F, Kreps SE, Bachelet M, Hainaut P, Bakonyi M, and Polla BS. Cadmium in the environment: sources, mechanisms of biotoxicity, and biomarkers. Rev Environ Health 15: 299-323, 2000.
63. Prada JA and Tsang RC. Biological mechanisms of environmentally induced causes of IUGR. Eur J Clin Nutr 52: S21-S28, 1998.
64. Rasmussen KM and Adams B. Annotation: cigarette smoking, nutrition, and birthweight. Am J Public Health 87: 543-544, 1997.
65. Salihu HM, Shumpert MN, Aliyu MH, Alexander MR, Kirby RS, and Alexander GR. Stillbirths and infant deaths associated with maternal smoking among mothers aged > or =40 years: a population study. Am J Perinatol 21: 121-129, 2004.
66. Salpietro CD, Gangemi S, Minciullo PL, Briuglia S, Merlino MV, Stelitano A, Cristani M, Trombetta D, and Saija A. Cadmium concentration concentration in maternal and cord blood and infant birth weight: a study on healthy non-smoking women. J Perinat Med 30: 395-399, 2002.
67. Schellscheidt J, Jorch G, and Menke J. Effects of heavy maternal smoking on intrauterine growth patterns in sudden infant death victims and surviving infants. Eur J Pediatr 157: 246-251, 1998.
68. Schoof E, Girstl M, Frobenius W, Kirschbaum M, Dorr HG, Rascher W, and Dotsch J. Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J Clin Endocrinol Metab 86: 1313-1317, 2001.
69. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, and Stewart PM. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 13: 799-804, 1998.
70. Sharara FI, Seifer DB, and Flaws JA. Environmental toxicants and female reproduction. Fertil Steril 70: 613-622, 1998.
71. Stewart PM, Rogerson FM, and Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 80: 885-890, 1995.
72. Stoica A, Katzenellenbogen BS, and Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 14: 545-553, 2000.
73. Sun K, Yang K, and Challis JR. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5′ -monophosphate pathway in cultured human placental and chorionic trophoblasts. Biol Reprod 58: 1379-1384, 1998.
74. Van der Veen F and Fox H. The effects of cigarette smoking on the human placenta: a light and electron microscopic study. Placenta 3: 243-256, 1982.
75. Van Hattum B, de Voogt P, and Copius Peereboom JW. An analytical procedure for the determination of cadmium in human placentae. Int J Environ Anal Chem 10: 121-133, 1981.
76. Waisberg M, Joseph P, Hale B, and Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192: 95-117, 2003.
77. Watkin RD, Nawrot T, Potts RJ, and Hart BA. Mechanisms regulating the cadmium-mediated suppression of Sp1 transcription factor activity in alveolar epithelial cells. Toxicology 184: 157-178, 2003.
78. Wier PJ, Miller RK, Maulik D, and DiSant'Agnese PA. Toxicity of cadmium in the perfused human placenta. Toxicol Appl Pharmacol 105: 156-171, 1990.
79. Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod 2: 129-132, 1997.
80. Zadorozhnaja TD, Little RE, Miller RK, Mendel NA, Taylor RJ, Presley BJ, and Gladen BC. Concentrations of arsenic, cadmium, copper, lead, mercury, and zinc in human placentas from two cities in Ukraine. J Toxicol Environ Health A 61: 255-263, 2000.
81. Zdravkovic T, Genbacev O, McMaster MT, and Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 26: S81-S86, 2005.
82. Zenzes MT, Krishnan S, Krishnan B, Zhang H, and Casper RF. Cadmium accumulation in follicular fluid of women in in vitro fertilization-embryo transfer is higher in smokers. Fertil Steril 64: 599-603, 1995.